The DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Multifunctional Theranostic Nanoparticles Based on Exceedingly Small Magnetic Iron Oxide Nanoparticles for T1-Weighted Magnetic Resonance Imaging and Chemotherapy
Abstract
The recently emerged exceedingly small magnetic iron oxide nanoparticles (ES-MIONs) (<5 nm) are promising T 1 -weighted contrast agents for magnetic resonance imaging (MRI) due to their good biocompatibility compared with Gd-chelates. However, the best particle size of ES-MIONs for T 1 imaging is still unknown because the synthesis of ES-MIONs with precise size control to clarify the relationship between the r 1 (or r 2 / r 1 ) and the particle size remains a challenge. In this study, we synthesized ES-MIONs with seven different sizes below 5 nm and found that 3.6 nm is the best particle size for ES-MIONs to be utilized as T 1 -weighted MR contrast agent. To enhance tumor targetability of theranostic nanoparticles and reduce the nonspecific uptake of nanoparticles by normal healthy cells, we constructed a drug delivery system based on the 3.6 nm ES-MIONs for T 1 -weighted tumor imaging and chemotherapy. The laser scanning confocal microscopy (LSCM) and flow cytometry analysis results demonstrate that our strategy of precise targeting via exposure or hiding of the targeting ligand RGD 2 on demand is feasible. The MR imaging and chemotherapy results on the cancer cells and tumor-bearing mice reinforce that our DOX@ES-MION3@RGD 2 @mPEG3 nanoparticles are promising for high-resolution T 1 -weighted MR imaging and precise chemotherapy of tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nanocarriers as an emerging platform for cancer therapy
Peer, D., Karp, J. M., Hong, S., Farokhzad, O. C., Margalit, R., & Langer, R. (2007) · Nature Nanotechnology · doi:10.1038/nnano.2007.387 · Cited by 8,710
Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., & Muller, R. N. (2008) · Chemical Reviews · doi:10.1021/cr068445e · Cited by 6,852
Inorganic Nanoparticles for MRI Contrast Agents
Na, H. B., Song, I. C., & Hyeon, T. (2009) · Advanced Materials · doi:10.1002/adma.200802366 · Cited by 1,781
Liu, J., Sun, Z., Deng, Y., Zou, Y., Li, C., Guo, X., Xiong, L., Gao, Y., Li, F., & Zhao, D. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200901566 · Cited by 1,057
Kim, B. H., Lee, N., Kim, H., An, K., Park, Y. I., Choi, Y., Shin, K., Lee, Y., Kwon, S. G., Na, H. B., et al. (2011) · Journal of the American Chemical Society · doi:10.1021/ja203340u · Cited by 947
Yang, K., Hu, L., Ma, X., Ye, S., Cheng, L., Shi, X., Li, C., Li, Y., & Liu, Z. (2012) · Advanced Materials · doi:10.1002/adma.201104964 · Cited by 943
Self-citationMultifunctional magnetic nanoparticles for targeted imaging and therapy
MCCARTHY, J., & WEISSLEDER, R. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.014 · Cited by 892
Exceedingly small iron oxide nanoparticles as positive MRI contrast agents
Wei, H., Bruns, O. T., Kaul, M. G., Hansen, E. C., Barch, M., Wiśniowska, A., Chen, O., Chen, Y., Li, N., Okada, S., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1620145114 · Cited by 489
Unni, M., Uhl, A. M., Savliwala, S., Savitzky, B. H., Dhavalikar, R., Garraud, N., Arnold, D. P., Kourkoutis, L. F., Andrew, J. S., & Rinaldi, C. (2017) · ACS Nano · doi:10.1021/acsnano.7b00609 · Cited by 411
Tromsdorf, U. I., Bruns, O. T., Salmen, S. C., Beisiegel, U., & Weller, H. (2009) · Nano Letters · doi:10.1021/nl902715v · Cited by 396
Cited by
Nanoparticle Surface Functionalization: How to Improve Biocompatibility and Cellular Internalization
Sanità, G., Carrese, B., & Lamberti, A. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.587012 · Cited by 765
Shen, Z., Liu, T., Li, Y., Lau, J., Yang, Z., Fan, W., Zhou, Z., Shi, C., Ke, C., Bregadze, V. I., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b06201 · Cited by 633
Self-citationNanomaterial-based blood-brain-barrier (BBB) crossing strategies
Xie, J., Shen, Z., Anraku, Y., Kataoka, K., & Chen, X. (2019) · Biomaterials · doi:10.1016/j.biomaterials.2019.119491 · Cited by 604
Self-citationStructure–Relaxivity Relationships of Magnetic Nanoparticles for Magnetic Resonance Imaging
Zhou, Z., Yang, L., Gao, J., & Chen, X. (2019) · Advanced Materials · doi:10.1002/adma.201804567 · Cited by 488
Self-citationJeon, M., Halbert, M. V., Stephen, Z. R., & Zhang, M. (2021) · Advanced Materials · doi:10.1002/adma.201906539 · Cited by 477
Versatile Types of Organic/Inorganic Nanohybrids: From Strategic Design to Biomedical Applications
Zhao, N., Yan, L., Zhao, X., Chen, X., Li, A., Zheng, D., Zhou, X., Dai, X., & Xu, F.-J. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00401 · Cited by 429
Self-citationTian, H., Zhang, T., Qin, S., Huang, Z., Zhou, L., Shi, J., Nice, E. C., Xie, N., Huang, C., & Shen, Z. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01320-5 · Cited by 426
Self-citationXie, W., Guo, Z., Gao, F., Gao, Q., Wang, D., Liaw, B.-S., Cai, Q., Sun, X., Wang, X., & Zhao, L. (2018) · Theranostics · doi:10.7150/thno.25220 · Cited by 391
Multifunctional magnetic iron oxide nanoparticles: an advanced platform for cancer theranostics
Zhao, S., Yu, X., Qian, Y., Chen, W., & Shen, J. (2020) · Theranostics · doi:10.7150/thno.42564 · Cited by 390
New opportunities and old challenges in the clinical translation of nanotheranostics
Gawne, P. J., Ferreira, M., Papaluca, M., Grimm, J., & Decuzzi, P. (2023) · Nature Reviews Materials · doi:10.1038/s41578-023-00581-x · Cited by 255
Wang, L., Shi, Y., Jiang, J., Li, C., Zhang, H., Zhang, X., Jiang, T., Wang, L., Wang, Y., & Feng, L. (2022) · Small · doi:10.1002/smll.202203678 · Cited by 71
Metadata
- Authors
- Shen, Z., Chen, T., Ma, X., Ren, W., Zhou, Z., Zhu, G., Zhang, A., Liu, Y., Song, J., Li, Z., Ruan, H., Fan, W., Lin, L., Munasinghe, J., Chen, X., & Wu, A.
- Venue
- ACS Nano
- Publisher
- American Chemical Society (ACS)
- Published
- 2017-10-19
- Volume
- 11
- Issue
- 11
- Pages
- 10992-11004
- ISSN
- 1936-0851 (ISSN-L)
- 1936-086X
- OpenAlex
- W2765209067
- Cited by
- 298
- References
- 49
- FWCI
- 9.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.